PixoTech® is a technology-service platform —— we provide imaging algorithms, hardware analyzers, a cloud data platform and a regulatory path. You focus on your reagents or your business; we handle all the rest of the technical development. From XLab co-development to CDMO manufacturing, a proven path to commercialization.
Whether you have mature strip chemistry, a health brand about to launch, or an academic research prototype — PixoTech® has a partnership path for you.
You have a unique strip formulation but lack clinical-grade algorithms, an analyzer, cloud integration and regulatory-filing capability. We provide full technical support so your strip skips 3–5 years of engineering.
You want to launch your own-brand home-testing product, or a companion diagnostic for an existing drug. We customize the UI, app and cloud dashboard so the whole product carries your brand.
Clinical trials, epidemiology, large-scale screening —— you need a reliable, scalable point-of-care testing solution. The XLab remote co-development model customizes rapidly for different biomarkers and shortens the validation cycle.
PixoTech® is a modular technology platform. You decide the assay you want —— the rest, from capture and analysis to storage and compliance, is delivered by us.
Full CDMO capability — six interlocking technical modules. Take the whole turnkey delivery, or just the pieces you need.
Intelligent colorimetric sensing and machine learning — custom qualitative / semi-quantitative / quantitative models for your strip, improving accuracy through continuous learning.
From a dedicated analyzer to a Bluetooth device, three PixoTech® forms to choose by use case, produced in certified plants with full quality control.
PixoHealth Hub handles data capture, dashboard generation and API integration — with built-in HIPAA-grade security and a GDPR-compliant data framework.
A white-labelable iOS / Android app, or SDK integration into your existing app. Includes standard modules for trends, reminders, AI guidance and educational content.
510(k), CE-IVD and TFDA filing experience — clinical-trial design consulting, technical-file preparation and audit-response support across markets.
An ISO 13485-certified supply chain — from PCB design, enclosure molding and assembly testing to global logistics — delivering your branded product end to end.
Four stages, each with clear deliverables and timeline expectations. This is the typical rhythm of a CDMO partnership — actual timing varies with biomarker complexity.
Start the conversation, sign an NDA, exchange strip samples and initial specs. The iXensor team assesses compatibility between your biomarker and the PixoTech® algorithm and provides an initial commercialization feasibility report.
iXensor ships a pre-embedded analyzer to your site to begin remote co-development. Batch-validation images go to the cloud and the iXensor algorithm team iterates until clinical-grade accuracy is reached.
Move into formal clinical-trial design and execution. iXensor provides the technical file, quality-management documents and regulator-communication support to complete an FDA 510(k), CE-IVD or TFDA submission.
After regulatory approval, move into production and launch prep — hardware manufacturing, app release, cloud deployment, marketing assets and channel support. iXensor provides ongoing algorithm maintenance and cloud hosting.
Building a smart diagnostic product is a long road —— hardware, software, regulatory, data; each step takes years. CDMO isn't about saving money — it's about buying time.
Leading health-industry brands and top accelerators
have chosen to work with us.
A world-leading platform for scaling rapid testing and diagnostics; a strategic partnership was announced at MEDICA 2022.
A major Japanese pharmaceutical company joined via strategic investment and signed an additional technology-licensing agreement.
Invited by J&J Innovation into JLABS @ Shanghai, gaining global-network acceleration resources.
Selected for the Roche-led Plug & Play Startup Creasphere program, alongside health startups worldwide.
Selected as a Merck Accelerator partner, gaining digital-health resources from the German pharma leader.
Listed on the Taipei Exchange, with transparency and governance following listed-company standards.
A BSI-certified ISO 13485 medical-device quality system that has passed multiple unannounced audits.
The PixoTech® platform's 100+ international patents span the U.S., EU, Taiwan, Japan and other major markets.
Whether you bring a strip formulation, a clinical protocol or a brand plan —— our BD team is happy to spend 30 minutes understanding your idea and tell you honestly whether PixoTech® can solve your problem. No obligation, just a technical discussion.